BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Stem cell
,
Amniocentesis
,
Fenofibrate
,
rs3825942
,
SNCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
crotamiton
Summary
General Info
Curated Studies
Most Correlated Studies
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Affymetrix]
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
Broad Connectivity Map (CMAP 2.0) compound database
Liver Pharmacology and Xenobiotic Response Repertoire
Livers of rat exposed to variety of hepatotoxic compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by …
Crotamiton derivative JM03 extends lifespan and improves oxidative and hypertonic stress resistance …
Crotamiton-loaded tea tree oil containing phospholipid-based microemulsion hydrogel for scabies trea…
Anogenital skin necrosis with fibrin thrombosis induced by crotamiton.
Amelioration of the abnormal phenotype of a new L1 syndrome mouse mutation with L1 mimetics.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.
Dose-finding Study of Moxidectin for Treatment of Scabies
Efficacy and Safety Study of Moxidectin in Adults With Scabies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ